Alzebari, A. M., Qadir, A. M. ., Rafaat, M. S., & Salihi, A. (2023). Therapeutic Potential of Heat Shock Protein 90 Inhibitors, Geldanamycin, and Analog Compounds in Precision Cancer Therapy. BioMed Target Journal, 1(2), 2–21. https://doi.org/10.59786/bmtj.122